Drugs and Clinical Trial (Amendment) Rules, 2023
The Union Government passed an amendment to the New Drugs and Clinical Trial Rules (2023).
- It is aimed at promoting clinical research in India and ensuring the conduct of ethical trials.
- Approval time for drugs discovered or developed in India is reduced to 30 days, while for drugs developed outside it is set at 90 days.
- Ethics Committees will monitor trials and determine compensation for adverse events.
- Orphan drugs, treating conditions affecting up to five lakh persons, are defined for the first time.
|
Clinical Trials
|
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Current Affairs
- 1 SEBI Norms for Finfluencers
- 2 Vibrant Villages Programme-II
- 3 Balancing National Security and Human Rights: The Rohingya Issue
- 4 PRAHAAR – National Counter-Terrorism Policy
- 5 AI Governance Framework & IndiaAI Mission
- 6 LWE Strategy – “Legacy & Thrust Areas”
- 7 e-Courts Mission Mode Project Phase III
- 8 National Urban Digital Mission (NUDM)
- 9 51st G7 Summit 2025
- 10 The SHANTI Act, 2025
